{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:08:59Z","timestamp":1778303339964,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pharma.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:57:06Z","timestamp":1776787026000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanospanlastic delivery of repurposed rosuvastatin for augmented wound healing"],"prefix":"10.1016","author":[{"given":"Ashish","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Mujib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himani","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit Deb","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipti","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2026.04.003_bib0255","doi-asserted-by":"crossref","first-page":"100179","DOI":"10.1016\/j.wndm.2020.100179","article-title":"The applied anatomy of human skin: a model for regeneration","volume":"28","author":"Abdo","year":"2020","journal-title":"Wound Med"},{"issue":"5","key":"10.1016\/j.pharma.2026.04.003_bib0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/wound.2021.0026","article-title":"Human wound and its burden: updated 2020 compendium of estimates","volume":"10","author":"Sen","year":"2021","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.pharma.2026.04.003_bib0265","series-title":"Human wounds and its burden: an updated compendium of estimates","author":"Sen","year":"2019"},{"key":"10.1016\/j.pharma.2026.04.003_bib0270","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41580-024-00715-1","article-title":"Cellular and molecular mechanisms of skin wound healing","volume":"25","author":"Pe\u00f1a","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharma.2026.04.003_bib0275","doi-asserted-by":"crossref","first-page":"1395479","DOI":"10.3389\/fimmu.2024.1395479","article-title":"Recent advances in molecular mechanisms of skin wound healing and its treatments","volume":"15","author":"Mamun","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.pharma.2026.04.003_bib0280","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/cells13070624","article-title":"Role of the skin immune system in wound healing","volume":"13","author":"Cioce","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.pharma.2026.04.003_bib0285","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2015.08.070","article-title":"Wound healing and treating wounds: chronic wound care and management","volume":"74","author":"Powers","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.pharma.2026.04.003_bib0290","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/wound.2015.0635","article-title":"Challenges in the treatment of chronic wounds","volume":"4","author":"Frykberg","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10.1016\/j.pharma.2026.04.003_bib0295","first-page":"76","article-title":"Possible drug repurposing and accelerated wound healing","volume":"11","author":"Patel","year":"2024","journal-title":"Regen Eng Transl Med"},{"key":"10.1016\/j.pharma.2026.04.003_bib0300","doi-asserted-by":"crossref","first-page":"105166","DOI":"10.1016\/j.jddst.2023.105166","article-title":"Repurposing ivermectin and ciprofloxacin in nanofibers for enhanced wound healing and infection control against MDR wound pathogens","volume":"90","author":"Kalangadan","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/wrr.12135","article-title":"Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus","volume":"22","author":"Hamed","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"4","key":"10.1016\/j.pharma.2026.04.003_bib0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/ph13040060","article-title":"The treatment of impaired wound healing in diabetes: looking among old drugs","volume":"13","author":"Spampinato","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharma.2026.04.003_bib0315","first-page":"1","article-title":"Harnessing nanotechnology for enhanced wound healing: integrating polymeric nanoparticles with rosuvastatin for targeted therapy","volume":"34","author":"Sarhan","year":"2025","journal-title":"J Drug Target"},{"key":"10.1016\/j.pharma.2026.04.003_bib0320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2018.11.002","article-title":"Mesenchymal stem cells associated with chitosan scaffolds loaded with rosuvastatin to improve wound healing","volume":"127","author":"Maged","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0325","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5114\/amsad\/196825","article-title":"Rosuvastatin accelerates the healing process of partial-thickness burn wounds in rats by reducing TNF-\u03b1 levels","volume":"9","author":"Marneri","year":"2024","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"4","key":"10.1016\/j.pharma.2026.04.003_bib0330","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/adv.21625","article-title":"Development and evaluation of rosuvastatin calcium based microparticles for solubility enhancement: an in vitro study","volume":"36","author":"Sarfraz","year":"2017","journal-title":"Adv Poly Technol"},{"key":"10.1016\/j.pharma.2026.04.003_bib0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2013.12.005","article-title":"Dermic diffusion and stratum corneum: a state of the art review of mathematical models","volume":"177","author":"Couto","year":"2014","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.pharma.2026.04.003_bib0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10408347.2018.1439364","article-title":"Analytical methods for the determination of rosuvastatin in pharmaceutical formulations and biological fluids: a critical review","volume":"48","author":"\u00c2ngelo","year":"2018","journal-title":"Crit Rev Anal Chem"},{"issue":"10","key":"10.1016\/j.pharma.2026.04.003_bib0345","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/jps.24556","article-title":"Investigation of pH influence on skin permeation behavior of weak acids using nonsteroidal anti-inflammatory drugs","volume":"104","author":"Chantasart","year":"2015","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.pharma.2026.04.003_bib0350","first-page":"0063","article-title":"Rosuvastatin calcium permeability evaluation using in vitro permeation test (IVPT) through human cadaver skin","volume":"3","author":"Rv","year":"2024","journal-title":"Int J Med Pharm Biol Sci"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2026.04.003_bib0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","article-title":"Spanlastics\u00a0\u2014\u00a0a novel nanovesicular carrier system for ocular delivery","volume":"413","author":"Kakkar","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2026.04.003_bib0360","doi-asserted-by":"crossref","first-page":"103102","DOI":"10.1016\/j.jddst.2022.103102","article-title":"Fabrication and optimization of raloxifene loaded spanlastics vesicle for transdermal delivery","volume":"68","author":"Ansari","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/1061186X.2024.2402750","article-title":"An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer","volume":"33","author":"Jahan","year":"2025","journal-title":"J Drug Target"},{"issue":"8","key":"10.1016\/j.pharma.2026.04.003_bib0370","doi-asserted-by":"crossref","first-page":"103647","DOI":"10.1016\/j.drudis.2023.103647","article-title":"Recent trends and updates on ultradeformable and elastic vesicles in ocular drug delivery","volume":"28","author":"Srivastava","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharma.2026.04.003_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1306-2","article-title":"Enhancement of transdermal delivery of haloperidol via spanlastic dispersions: entrapment efficiency vs. particle size","volume":"20","author":"Fahmy","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2026.04.003_bib0380","doi-asserted-by":"crossref","first-page":"122068","DOI":"10.1016\/j.ijpharm.2022.122068","article-title":"Spanlastic nanovesicles for enhanced ocular delivery of vanillic acid: design, in vitro characterization, and in vivo anti-inflammatory evaluation","volume":"625","author":"Ibrahim","year":"2022","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0385","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","article-title":"Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund's adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway","volume":"26","author":"El Menshawe","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.pharma.2026.04.003_bib0390","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1208\/s12249-016-0488-0","article-title":"Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis","volume":"17","author":"Mahtab","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.pharma.2026.04.003_bib0395","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/03639045.2023.2244075","article-title":"Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model","volume":"49","author":"Kataria","year":"2023","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2026.04.003_bib0400","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40005-014-0149-9","article-title":"Terbinafine hydrochloride loaded nanoemulsion based gel for topical application","volume":"45","author":"Karri","year":"2015","journal-title":"J Pharm Investig"},{"issue":"5","key":"10.1016\/j.pharma.2026.04.003_bib0405","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/00914037.2018.1443932","article-title":"Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery","volume":"68","author":"Chauhan","year":"2019","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0410","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S1984-82502015000100007","article-title":"Physical chemistry evaluation of stability, spreadability, in vitro antioxidant, and photo-protective capacities of topical formulations containing Calendula officinalis L. leaf extract","volume":"51","author":"Deuschle","year":"2015","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.pharma.2026.04.003_bib0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","article-title":"Controlled drug release from pharmaceutical nanocarriers","volume":"125","author":"Lee","year":"2015","journal-title":"Chem Eng Sci"},{"key":"10.1016\/j.pharma.2026.04.003_bib0420","doi-asserted-by":"crossref","first-page":"106228","DOI":"10.1016\/j.jddst.2024.106228","article-title":"Box\u2013Behnken design based optimized Quercetin nano formulation for palliative treatment of atopic dermatitis","volume":"101","author":"Singh","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"10.1016\/j.pharma.2026.04.003_bib0425","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/0974-8490.188880","article-title":"Wound healing activity of silibinin in mice","volume":"8","author":"Samanta","year":"2016","journal-title":"Pharmacogn Res"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0430","doi-asserted-by":"crossref","first-page":"38748","DOI":"10.1038\/srep38748","article-title":"In vivo assessment of antioxidant and wound healing improvement of a new schiff base derived Co (ii) complex in rats","volume":"6","author":"El-Ferjani","year":"2016","journal-title":"Sci Rep"},{"issue":"48","key":"10.1016\/j.pharma.2026.04.003_bib0435","first-page":"288","article-title":"Wound healing activity and chemical standardization of Eugenia pruniformis Cambess","volume":"12","author":"de Albuquerque","year":"2016","journal-title":"Pharmacogn Mag"},{"issue":"3","key":"10.1016\/j.pharma.2026.04.003_bib0440","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/9780470942390.mo130135","article-title":"Studying wound repair in the mouse","volume":"3","author":"Tan","year":"2013","journal-title":"Curr Protoc Mouse Biol"},{"issue":"5","key":"10.1016\/j.pharma.2026.04.003_bib0445","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/0253-7613.117759","article-title":"Wound healing activity of Sida cordifolia Linn. in rats","volume":"45","author":"Pawar","year":"2013","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharma.2026.04.003_bib0450","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s12247-023-09711-y","article-title":"Nanospanlastics as a novel approach for improving the oral delivery of resveratrol in lipopolysaccharide-induced endotoxicity in mice","volume":"18","author":"Younis","year":"2023","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.pharma.2026.04.003_bib0455","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.2147\/IJN.S319348","article-title":"Implementing spanlastics for improving the ocular delivery of clotrimazole: in vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study","volume":"16","author":"Abdelbari","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.pharma.2026.04.003_bib0460","doi-asserted-by":"crossref","first-page":"127246","DOI":"10.1016\/j.colsurfa.2021.127246","article-title":"Investigations on the role of edge activator upon structural transitions in Span vesicles","volume":"627","author":"Rathod","year":"2021","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"6","key":"10.1016\/j.pharma.2026.04.003_bib0465","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jsde.12694","article-title":"The effect of edge activator on the evolution and application of a nonionic surfactant: the elastic vesicular system","volume":"26","author":"Sarolia","year":"2023","journal-title":"J Surfactants Deterg"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2026.04.003_bib0470","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.pharma.2026.04.003_bib0475","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/pharmaceutics14071419","article-title":"Formulation-by-design of efinaconazole spanlastic nanovesicles for transungual delivery using statistical risk management and multivariate analytical techniques","volume":"14","author":"Almuqbil","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2026.04.003_bib0480","first-page":"100201","article-title":"Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: in-vitro characterization, microbiological assessment, corneal permeability and in-vivo study","volume":"6","author":"Agha","year":"2023","journal-title":"Int J Pharm X"},{"issue":"1","key":"10.1016\/j.pharma.2026.04.003_bib0485","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/ph14010068","article-title":"Formulation and optimization of nanospanlastics for improving the bioavailability of green tea epigallocatechin gallate","volume":"14","author":"Mazyed","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2026.04.003_bib0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.03.005","article-title":"Enhanced non-invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: fabrication, in-vitro characterization, and comparative ex-vivo permeation studies","volume":"522","author":"Al-Mahallawi","year":"2017","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.pharma.2026.04.003_bib0495","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/ph17121614","article-title":"Spanlastic nano-vesicles: a novel approach to improve the dissolution, bioavailability, and pharmacokinetic behavior of famotidine","volume":"17","author":"Almohamady","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharma.2026.04.003_bib0500","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.2147\/DDDT.S265167","article-title":"Formulation of nanospanlastics as a promising approach for improving the topical delivery of a natural leukotriene inhibitor (3-Acetyl-11-Keto-\u03b2-Boswellic Acid): Statistical optimization, in vitro characterization, and ex vivo permeation study","volume":"14","author":"Badria","year":"2020","journal-title":"Drug Des Devel Ther"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:09:58Z","timestamp":1778299798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450926000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"alternative-id":["S0003450926000623"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.04.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanospanlastic delivery of repurposed rosuvastatin for augmented wound healing","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}